Investors
Building value with strong partners
Current shareholders
Major shareholders include the institutional investor EIC Fund, a 5 bn EUR fund investing exclusively in innovative and disruptive technologies, and four family offices represented by a single point of contact.
Annual General Meeting
Notices and documents for shareholder meetings are published in our news.
See newsActive grants
- Marie Skłodowska-Curie Actions Doctoral Network B-ACTIVE, Horizon 2022, grant agreement No. 101120187, 2024–2028.
- Together with Uppsala University, Swedish Cystic Fibrosis Foundation, 2026.
Selected completed grants
- H2020 SME phase 2 grant WHILYAs for the first-in-human RCT phase 1 clinical trial of ILP100-Topical.